Background Interstitial lung disease is a known complication of rheumatoid arthritis, with a
lifetime risk of developing the disease in any individual of 7· 7%. We aimed to assess the …

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with a strong
female predilection. Cardiovascular morbidity and mortality is a frequent complication …

There is an urgent need for clinical trials to examine both the lipid-lowering and
inflammatory hypotheses of atherosclerosis in rheumatoid arthritis and systemic lupus …

Objective. To determine the relationship between serum vitamin D and markers of
subclinical cardiovascular disease (CVD) in patients with SLE. Methods. We recruited SLE …

Objective. Accelerated atherosclerosis and premature coronary heart disease (CHD) are
recognized complications of systemic lupus erythematosus (SLE), but the exact etiology …

Patients with systemic lupus erythematosus (SLE) have accelerated cardiovascular disease
and dysfunctional endothelial repair mechanisms. Myeloid angiogenic cells (MACs), derived …

Background Patients with SLE display marked clinical and immunlogical heterogeneity. The
purpose of the study was to investigate patterns of serum cytokines in patients with active …

Background Patients with systemic lupus erythematosus (SLE) are at an increased risk of
infection relative to the general population. We aimed to describe the frequency and risk …

Objectives The aim of the current study was to compare levels of vascular cell adhesion
molecule-1 (VCAM-1) and E-selectin in lupus patients and controls and to investigate their …

Objective Patients with systemic lupus erythematosus (SLE) have a higher rate of premature
death compared to the general population, suggesting a phenotype of premature …